Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Françoise Roquet-Banères"'
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2021, 37 (11), pp.993-1001. ⟨10.1051/medsci/2021164⟩
médecine/sciences, EDP Sciences, 2021, 37 (11), pp.993-1001. ⟨10.1051/medsci/2021164⟩
Mycobacterium abscessusest une bactérie non tuberculeuse, environnementale, à croissance rapide, qui est responsable d’infections pulmonaires sévères, notamment chez les patients atteints de mucoviscidose. Le traitement actuel combine l’utili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362fe8c15d1c9c1764fd3db0bbcd63ad
https://hal.archives-ouvertes.fr/hal-03462547/document
https://hal.archives-ouvertes.fr/hal-03462547/document
Autor:
Françoise Roquet-Banères, Graham F. Hatfull, Rebekah M. Dedrick, Claire Hamela, Matt D. Johansen, Laurent Kremer, Matthéo Alcaraz
Publikováno v:
Disease Models & Mechanisms
Disease Models & Mechanisms, Cambridge Company of Biologists, 2021, 14 (9), pp.dmm049159. ⟨10.1242/dmm.049159⟩
Disease Models & Mechanisms, 2021, 14 (9), pp.dmm049159. ⟨10.1242/dmm.049159⟩
Disease Models & Mechanisms, Vol 14, Iss 9 (2021)
Disease Models & Mechanisms, Cambridge Company of Biologists, 2021, 14 (9), pp.dmm049159. ⟨10.1242/dmm.049159⟩
Disease Models & Mechanisms, 2021, 14 (9), pp.dmm049159. ⟨10.1242/dmm.049159⟩
Disease Models & Mechanisms, Vol 14, Iss 9 (2021)
Infection by multidrug-resistant Mycobacterium abscessus is increasingly prevalent in cystic fibrosis (CF) patients, leaving clinicians with few therapeutic options. A compassionate study showed the clinical improvement of a CF patient with a dissemi
Autor:
Oluwakemi Ebenezer, Laurent Kremer, Parvesh Singh, Anu Rani, Paul Awolade, Françoise Roquet-Banères, Vipan Kumar, Matt D. Johansen, Sumanjit
Publikováno v:
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 2020, 30 (22), pp.127576. ⟨10.1016/j.bmcl.2020.127576⟩
Bioorganic and Medicinal Chemistry Letters, Elsevier, 2020, 30 (22), pp.127576. ⟨10.1016/j.bmcl.2020.127576⟩
Bioorganic and Medicinal Chemistry Letters, 2020, 30 (22), pp.127576. ⟨10.1016/j.bmcl.2020.127576⟩
Bioorganic and Medicinal Chemistry Letters, Elsevier, 2020, 30 (22), pp.127576. ⟨10.1016/j.bmcl.2020.127576⟩
International audience; A series of 4-aminoquinoline-isoindoline-dione-isoniazid triads were synthesized and assessed for their anti-mycobacterial activities and cytotoxicity. Most of the synthesized compounds exhibited promising activities against t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389c017dcecc86a28657b913c297d748
https://www.hal.inserm.fr/inserm-03082751/file/4-aminoquinoline-isoindoline-dione-INH-BMCL.pdf
https://www.hal.inserm.fr/inserm-03082751/file/4-aminoquinoline-isoindoline-dione-INH-BMCL.pdf
Autor:
Oluseye K. Onajole, Clément Raynaud, Diane J. Ordway, Jozef Stec, Matt D. Johansen, Laurent Kremer, Françoise Roquet-Banères, Alan P. Kozikowski, Wassim Daher
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 2020, [Epub ahead of print] (5), pp.AAC.02548-19. ⟨10.1128/AAC.02548-19⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, [Epub ahead of print], pp.AAC.02548-19. ⟨10.1128/AAC.02548-19⟩
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, [Epub ahead of print] (5), pp.AAC.02548-19. ⟨10.1128/AAC.02548-19⟩
Antimicrobial Agents and Chemotherapy, 2020, [Epub ahead of print] (5), pp.AAC.02548-19. ⟨10.1128/AAC.02548-19⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, [Epub ahead of print], pp.AAC.02548-19. ⟨10.1128/AAC.02548-19⟩
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, [Epub ahead of print] (5), pp.AAC.02548-19. ⟨10.1128/AAC.02548-19⟩
New drugs or therapeutic combinations are urgently needed against Mycobacterium abscessus . Previously, we demonstrated the potent activity of indole-2-carboxamides 6 and 12 against M. abscessus . We show here that these compounds act synergistically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ee5825442ef398ea3e449b7d69c20ed
https://hal.science/hal-02479144
https://hal.science/hal-02479144
Autor:
Laurent Kremer, Matt D. Johansen, Jarosław Dziadek, Katarzyna Gobis, Alan P. Kozikowski, Mickaël Blaise, Jean-Louis Herrmann, Clément Raynaud, Wassim Daher, Françoise Roquet-Banères, Oluseye K. Onajole
Publikováno v:
ACS Infectious Diseases
ACS Infectious Diseases, American Chemical Society, 2019, ⟨10.1021/acsinfecdis.9b00389⟩
ACS Infectious Diseases, American Chemical Society, 2020, 6 (2), pp.324-337. ⟨10.1021/acsinfecdis.9b00389⟩
ACS Infectious Diseases, 2020, 6 (2), pp.324-337. ⟨10.1021/acsinfecdis.9b00389⟩
ACS Infectious Diseases, American Chemical Society, 2019, ⟨10.1021/acsinfecdis.9b00389⟩
ACS Infectious Diseases, American Chemical Society, 2020, 6 (2), pp.324-337. ⟨10.1021/acsinfecdis.9b00389⟩
ACS Infectious Diseases, 2020, 6 (2), pp.324-337. ⟨10.1021/acsinfecdis.9b00389⟩
International audience; The prevalence of pulmonary infections due to non-tuberculous mycobacteria such as Mycobacterium abscessus, has been increasing and surpassing tuberculosis (TB) in some industrialized countries. Due to intrinsic resistance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183b0b086e33dc9e7c3bc3eb9c4c263e
https://hal.archives-ouvertes.fr/hal-02424752
https://hal.archives-ouvertes.fr/hal-02424752
Autor:
Laurent Kremer, Yushu Chen, Christian Dupont, Anne-Kathrin Witt, Shu-Sin Chng, Florian P. Maurer, Christophe Biot, Françoise Roquet-Banères, Mickaël Blaise, Faustine Dubar, Zhujun Xu, Yann Guérardel
Publikováno v:
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2019, pp.jbc.RA119.010135. ⟨10.1074/jbc.RA119.010135⟩
Journal of Biological Chemistry, 2019, pp.jbc.RA119.010135. ⟨10.1074/jbc.RA119.010135⟩
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2019, pp.jbc.RA119.010135. ⟨10.1074/jbc.RA119.010135⟩
Journal of Biological Chemistry, 2019, pp.jbc.RA119.010135. ⟨10.1074/jbc.RA119.010135⟩
Mycobacterium tuberculosis, the causative agent of tuberculosis, remains a major human pathogen, and current treatment options to combat this disease are under threat because of the emergence of multidrug-resistant and extensively drug-resistant tube
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c5247b7889220800674e0e56d78253e
https://hal.archives-ouvertes.fr/hal-02324703
https://hal.archives-ouvertes.fr/hal-02324703
Autor:
Laurent Kremer, Mickaël Blaise, Daniela Rodriguez-Rincon, Albertus Viljoen, Julian Parkhill, Françoise Roquet-Banères, Ana Victoria Gutiérrez, Matthias Richard, R. Andres Floto, Isobel Everall
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2019, 63 (1), ⟨10.1128/AAC.01316-18⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2019, 63 (1), ⟨10.1128/AAC.01316-18⟩
New therapeutic approaches are needed against Mycobacterium abscessus, a respiratory mycobacterial pathogen that evades efforts to successfully treat infected patients. Clofazimine and bedaquiline, two drugs used for the treatment of multidrug-resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7abf98cf6a6d4371421900f72fc45e09
https://hal.archives-ouvertes.fr/hal-02137498
https://hal.archives-ouvertes.fr/hal-02137498
Autor:
Maxime Gualtieri, Zakia Morichaud, Jean-Paul Leonetti, Konstantin Brodolin, Françoise Roquet-Banères, Audrey Tupin
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, Elsevier, 2010, 35 (6), pp.519-23. ⟨10.1016/j.ijantimicag.2009.12.017⟩
International Journal of Antimicrobial Agents, Elsevier, 2010, 35 (6), pp.519. ⟨10.1016/j.ijantimicag.2009.12.017⟩
International Journal of Antimicrobial Agents, Elsevier, 2010, 35 (6), pp.519-23. ⟨10.1016/j.ijantimicag.2009.12.017⟩
International Journal of Antimicrobial Agents, Elsevier, 2010, 35 (6), pp.519. ⟨10.1016/j.ijantimicag.2009.12.017⟩
International audience; The first antibiotic of the ansamycin family, rifampicin (RIF), was isolated in 1959 and was introduced into therapy in 1962; it is still a first-line agent in the treatment of diseases such as tuberculosis, leprosy and variou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92996a7568d127d534cbcd50c0cccc01
https://hal.archives-ouvertes.fr/hal-00509068
https://hal.archives-ouvertes.fr/hal-00509068